RxAll
View this profile on Briter Intelligence platform
Type
startup
Founded
2016
Funding captured
$4.0m
Deals captured
10
About RxAll
RxAll is an AI-hyperspectral platform for authenticating medicines. The platform uses a proprietary molecular sensor device with a cloud based IP-protected AI algorithm and database of spectral signatures of medicines to carry out non-destructive pill authentication.
RxAll funding captured (10)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Grant | Unspecified | Jan 22, 2022 | undisclosed |  USAID |
| **************** | **************** | **************** | undisclosed | **************** |
| **************** | **************** | **************** | undisclosed | **************** |
| **************** | **************** | **************** | $2.3m | **************** |
| **************** | **************** | **************** | $900.0k | **************** |